Pharmacoepidemiology at Nordic School of Public Health NHV: Examples from 1999 to 2014

Abstract

Background: Pharmacoepidemiology is a branch of public health and had a place at the Nordic School of Public Health. Courses, Master’s theses and Doctorates of Public Health (DrPH) in Pharmacoepidemiology were a relatively minor, but still important part of the school’s activities. Methods: This paper gives a short background, followed by some snapshots of the activities at NHV, and then some illustrative case-studies. These case-studies list their own responsible co-authors and have separate reference lists. Results: In the Nordic context, NHV was a unique provider of training and research in pharmacoepidemiology, with single courses to complete DrPH training, as well as implementation of externally-funded research projects. Conclusions: With the closure of NHV at the end of 2014, it is unclear if such a comprehensive approach towards pharmacoepidemiology will be found elsewhere in the Nordic countries.

Keywords

Case studies Doctor of Public Health Doctorate degree higher education Master’s degree Nordic countries pharmacoepidemiology prescribed medicines theses research training

Get full access to this article

View all access options for this article.

References

Strom

. Pharmacoepidemilogy. 3rd ed. New York: John Wiley and Sons, 2000.

WHO Collaborating Centre for Drug Statistics and Methodology. International language for drug utilization research. Oslo: Norwegean Institute of Public Health. Available from: http://www.whocc.no (accessed 25 January 2015).

Uppsala Monitoring Centre. To improve worldwide patient safety. Uppsala: Uppsala Monitoring Centre. Available from: http://www.who-umc.org/ (accessed 25 January 2015).

Berg

. The ever increasing use of acid suppressive therapy. Descriptive analysis of data from the national wholesale and prescription databases on the consumption of proton pump inhibitor in Norway. Göteborg: Nordic School of Public Health, 2007.

Jonsson

Stålsby Lundborg

. Exploring unexplained twofold differences in sales of cardiovascular drugs between two neighbouring Swedish municipalities. Pharmacoepidemiol Drug Safety 2005;14:349–55.

Silwer

. Public health aspects of pharmaceutical prescription patterns, exemplified by treatment for prevention of cardiovascular disease. Göteborg: Nordic School of Public Health, 2007.

Silwer

Johansson

Stålsby Lundborg

. Drug prescribing in public primary care centres: Results from prescription studies 1988–1997 in the county of Halland, Sweden. Scand J Prim Health Care 2002;20:236–41.

Silwer

Stålsby Lundborg

. Drug prescribing in primary care related to patient age: Trends in a 10-year repeated prescription study in a Swedish province. Eur J Gen Pract 2005;11:23–8.

Silwer

Stålsby Lundborg

. Patterns of drug use during a 15-year period: Data from a Swedish county 1988–2002. Pharmacoepidemiol Drug Safety 2005;14:813–20.

10.

Silwer

Petzold

Hallas

. Statins as cause of NSAID use: An analysis of prescription symmetry. Pharmacoepidemiol Drug Safety 2006;15:510–1.

11.

Silwer

Stålsby Lundborg

Petzold

. Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden; individual data from national registers. Pharmacoepidemiol Drug Safety 2008;17:37–42.

12.

Silwer

Wahlström

Stålsby Lundborg

. Views on primary prevention of cardiovascular disease: An interview study with Swedish GPs. BMC Fam Pract, 2010;11:44.